Paroxetine hydrochloride or Paxil is a psychotropic drug. It is used to treat depression, social anxiety disorder, generalised anxiety disorder, panic disorder, obsessive compulsive disorder and post traumatic stress disorder. Depression is one such disease which is c...

DRUGS in the Selective Serotonin Reuptake Inhibitor (SSRI) group are typically used for the treatment of depression and general anxiety disorders. However, it has been seen that they are also very effective in the treatment of premenstrual syndrome (PMS) and premenstr...

It was estimated that every year the amount of people who suffer from panic attacks is increasing. Panic attacks are the very first symptoms of a panic disorder. There are many approaches to a panic disorder. But one thing is clear a panic disorder is a very serious p...

The FDA is issuing a warning about the possibility of worsening depression or suicidal thoughts in people who take any of many popular antidepressants. The FDA is requesting labeling changes on these antidepressants; warning of possible suicide, worsening depr...

WASHINGTON (Reuters) - U.S. Sen. Charles Grassley asked regulators Thursday to investigate whether drugmaker GlaxoSmithKline Plc withheld data about a risk of suicide linked to its anxiety disorder drug Paxil. Grassley, a Republican from Iowa, said in a letter that a...

Who among us has never been in a large group of people and felt timid, nervous, and even downright terrified? Feelings such as these can happen from time to time, especially if we are a generally shy person. But when feelings of fear and panic are present in all situa...

Tablet Bowel Cleansing Prep for Colonoscopy Approved in United Kingdom RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for Diacol[TM] 1...

The U.S. Food and Drug Administration (FDA) is recommending that the anti-depressant medication paroxetine hydrochloride (marketed in the United States under the name Paxil) not be used to treat major depressive disorder in children and adolescents, though the ag...

Business Editors/Health/Medical Writers WESTON, Fla.--(BUSINESS WIRE)--April 26, 2004 Apotex Corp. today praised the decision of the U.S. Court of Appeals for the Federal Circuit holding that GSK's U.S. Patent No. 4,721,723, the patent covering Paxil Pax·il (...

Business Editors/Health/Medical Writers WESTON, Fla.--(BUSINESS WIRE)--Sept. 8, 2003 Apotex Corp. today announced that it has launched paroxetine paroxetine /par·ox·e·tine/ (pah-rok´se-ten) a selective serotonin uptake inhibitor used as the hydrochloride s...

Business Editors & Health/Medical Writers ADVISORY...for Tuesday (April 17) NOTE TO EDITORS: Multimedia Assets Available With This Story Include Audio, Graphics, Logos, Text News Releases, Video --(BUSINESS WIRE) GlaxoSmithKline announced that the U.S. Food ...

Apotex late last month announced that the FDA approved its abbreviated new drug application for paroxetine hydrochloride tablets, 10 mg, 20 mg, 30 mg and 40mg, which is the generic equivalent of GlaxoSmithKline's Paxil. ...

Pharmaco-Behavioral Therapy in Treatment of Premature Ejaculation, Amr I. El-Meliegy and Hussein H. Ghanem, Amr El-Meliegy, Saudi Arabia ...

A 21-year-old male with a 7-year history of depression that had failed to respond to pharmacological treatment received 4 g/day of the ethyl ester of eicosapentaenoic acid (>95% purity; supplied as LAX-101; Laxdale Research, Stirling, Scotland). He continued on par...

Apotex received tentative FDA approval of its abbreviated new drug application to market paroxetine hydrochloride tablets, the generic equivalent of GlaxoSmithKline's antidepressant Paxil (paroxetine), which boasted sales of $1.8 billion in the United States last year...

Mylan and its subsidiary Mylan Pharmaceuticals have entered into an agreement with GlaxoSmithKline in relation to paroxetine hydrochloride extended-release tablets, the generic version of Paxil CR. ...

Apotex Corp. filed for an injunction against GlaxoSmithKline and the FDA for the removal of six of the manufacturer's Paxil patents from the agency's Orange Book. Apotex said the listing of these additional patents indefinitely delays Apotex's own launch of paroxetine...